Abstract 3263: Where sensitivity meets complexity: Electrophoretic assessment of genomic DNA integrity at low concentrations and for FFPE samples using DIN-based analysis
Abstract DNA quality is a critical metric of success in downstream applications such as next-generation sequencing (NGS). However, formalin-fixed paraffin-embedded (FFPE) tissues and low-input sources like dried blood spots and buccal swabs often yield fragmented or chemically modified DNA, complicating quality control and subsequent analysis. To evaluate the impact of various sample sources on sample quality and integrity, genomic DNA (gDNA) was extracted from whole blood, dried blood spots, buccal swabs, saliva, and two FFPE tissue types using various commercial kits. Samples were analyzed on an automated electrophoresis platform and a high-sensitivity assay providing a DNA Integrity Number (DIN) to quantify DNA quality. For all samples DIN values across a broad concentration range were successfully generated showing the varying levels of degradation patterns. DIN values were reproducible across replicates and concentrations, confirming assay robustness, however FFPE samples showed significant DIN variability depending on the extraction method. DIN-based electrophoretic analysis offers a reproducible and objective measure of gDNA integrity, making it suitable for low-concentration and degraded samples in genomics workflows requiring stringent quality control, such as NGS. Citation Format: Solange Borg, Isabell Priester, Annika Dorn, Tim Butler. Where sensitivity meets complexity: Electrophoretic assessment of genomic DNA integrity at low concentrations and for FFPE samples using DIN-based analysis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3263.
Authors
- A Dorn (ORCID: https://orcid.org/0000-0002-0749-8425)
- Solange Borg
- Isabell Priester
- Tim Butler
Institutions
- Agilent Technologies (United States) (US)
Publication Details
- Journal
- Cancer Research
- Published
- 2026-04-03
- DOI
- https://doi.org/10.1158/1538-7445.am2026-3263
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00